Healio: Beta-cell function improved in men with Type 2 diabetes

diabetes in men

Men with Type 2 diabetes who received acipimox as an add-on to 3 weeks of Farxiga therapy saw improved beta-cell function and beta-cell sensitivity to glucose beyond Farxiga alone; however, the addition of the lipolysis inhibitor did not cause further improvement in insulin sensitivity, according to research in The Journal of Clinical Endocrinology & Metabolism.

Aurora Merovci, M.D., of the division of diabetes at The University of Texas Health Science Center at San Antonio, and colleagues analyzed data from 14 men with Type 2 diabetes.

Read the full story at Healio

Share This Article!